Workflow
Bionexus Gene Lab (BGLC) - 2019 Q1 - Quarterly Report
BGLCBionexus Gene Lab (BGLC)2019-05-15 17:15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-------------------------------------------------------------------------------|------------------------------------------| | For the transition period from ________ | to ____ ...